Cross the river from Boston into Cambridge on a weekday and the buildings around Kendall Square are laboratories with lobbies. The people leaving them at six are scientists, clinicians, engineers and the marketing teams that work for companies whose products are drugs, devices, diagnostics, research tools and software for hospitals. Down the road are the universities, and around them the education companies that sell to students and to schools. A creator arriving here with a portfolio of skincare unboxings meets a market in which the person who reviews the video may well have a doctorate, and in which every adjective is a claim somebody has to be able to defend.
That is the Boston mechanism: the reviewer is a scientist. It shapes what a brief looks like, how long a job takes to close, what a creator can say on camera, and which creators the market keeps.
Every adjective is a claim
The review is scientific before it is legal
In most markets a brand's review of a creator video is about tone and brand. Here it is about accuracy first. A company that sells a diagnostic or a research instrument has a medical, scientific or regulatory affairs function that reads the script the way it reads a publication, and "faster", "better", "gentle" and "clinically" are words that trigger a request for the evidence. The Federal Trade Commission's influencer guidance says the same thing in one line: a creator cannot make claims that would require proof the advertiser does not have, and its own example is scientific proof that a product treats a health condition. The Houston guide describes a medical-center market from the patient side; Boston is the same discipline applied to the company's own products, and the review is stricter because the company's reputation with its scientific customers depends on it.
What a creator can say
The workable rule is to describe experience and process, never outcome: what the product is, how it is used, what the experience of using it was, what the creator noticed, with the brand supplying any statement about what the product does. The script in a regulated category is a compliance document, and the San Francisco guide makes the same point about fintech; the Boston addition is that the reviewer may send the script back with citations. A creator who treats that as collaboration rather than interference gets the second job.
The cycles are long
Compliance review takes time, procurement takes time, and a brief that would close in a day in Austin can take weeks here. That changes cash flow, not the work: a creator in this market needs several jobs in flight at different stages, and needs the payment terms in writing from the start, because a corporation that took weeks to approve a script will pay on its own terms, net-30 being the common one. The guide to getting paid in the United States covers the sequence.
The buyers, and what each one orders
| Buyer | What it orders from a creator | What the reviewer checks |
|---|---|---|
| Biotech, devices, diagnostics | Explainers, patient or user experience, recruitment for trials and for jobs | Every claim against evidence; wording supplied by regulatory affairs |
| Hospitals and health systems | Patient-facing explainers, employer content | Accuracy, patient privacy, tone approved by communications |
| Universities and education companies | Student-experience video, course and program content, admissions | Truthfulness about outcomes, consent of anyone recognizable on campus |
| Consumer and software brands | Standard ad creative, test batches | Brand and performance, as elsewhere |
The fourth row exists because Boston also has ordinary consumer brands and a software sector, and their briefs look like the ones in the rest of the country, whereas the first three rows are the reason a creator moves here or stays.
Education is a category of its own
Universities, colleges and the education companies around them are large buyers of creator-style video: campus life, program explainers, admissions content, online course promotion. The creator is often a student or a recent graduate, the content is about an experience rather than a product, and two rules apply that product work does not have. Anyone recognizable on a campus is someone the university's communications office will want a release from, and the office decides what counts as consent, not the creator; and any statement about what a program leads to, a job, a salary, an admission rate, is a claim the institution has to support, which is why the script for a student-experience video is reviewed like a press release. The pay is modest by biotech standards and the volume is steady by any standard.
Winter, and the city on camera
Boston's winter is long, and a brand that wants the city on camera schedules for the months when the city is worth looking at. Most work is indoors and much of it is remote: a device explainer is filmed at a desk, a software walkthrough on a screen, a student video on a phone between classes. When a shoot does need a public location, the city and the many separate municipalities around it each administer their own rules for commercial filming, and this guide does not state them; a brand that wants a named location asks the relevant city office, and that answer belongs in the brief.
Being kept
The creators this market keeps are the ones the reviewer trusts: people who read the brief's constraints as the job rather than as an obstacle, who ask what evidence sits behind a claim before saying it, and whose portfolio shows a piece in a regulated category, delivered clean the first time. What usually stops a creator from getting that first regulated piece is the belief that one needs a scientific background. One does not; one needs to be careful, and to show it. A spec explainer for a product the creator uses, with every claim removed and the experience kept, labeled as spec, is the portfolio piece that opens a Boston door.
Sources
Checked on 20 September 2026. This guide is not legal or tax advice. Where this guide and the official source disagree, the official source prevails.
